However, many women with BRCA mutations perceive MHT as unsafe, due to concerns about their already elevated breast cancer ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited ...

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Some experts believe the cancer label can be inappropriate for certain low-risk conditions and advocate dropping the C-word.

Receiving neoadjuvant endocrine therapy enabled many postmenopausal patients with ER+, HER2- breast cancer to undergo breast-conserving surgery.

Younger age at diagnosis did not appear to affect outcomes among women with breast cancer who harbor BRCA mutations, ...

Breast cancer comes with many variables. A pair of powerful genomic tests can help women and their care teams make ...

The test is now ordered by breast surgeons or radiation oncologists in more than 85% of the top 50 U.S. cancer centers.